Yura A, Kiuchi Y, Uchikawa T, Uchida J, Yamazaki K, Oguchi K
Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.
Brain Res. 1996 Oct 28;738(1):96-102. doi: 10.1016/0006-8993(96)00762-7.
Effects of Ca2+ on [3H]5-hydroxytryptamine (5-HT) uptake into rat cortical synaptosomes were studied. The uptake was enhanced in the presence of Ca2+ in Krebs-Ringer medium and the uptake at 0.3-5 mM Ca2+ was 2.4-2.7 times greater than that observed in the absence of Ca2+. The maximal increase at the concentration of 1 mM Ca2+ was achieved after 2 min preincubation. Ca(2+)-dependent enhancement of the [3H]5-HT uptake reflected an increase in Vmax of the uptake process. However, Kd and Bmax values for [3H]paroxetine were not significantly changed in the presence of 1 mM Ca2+ compared with Ca(2+)-free condition. On the other hand, uptake was still enhanced after synaptosomes were washed with Ca(2+)-free after preincubation with 1 mM Ca2+. Staurosporine (a protein kinase C inhibitor) and wortmannin (a myosin light chain kinase inhibitor) did not affect Ca(2+)-dependent enhancement of the uptake, whereas 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazin e (KN-62, an inhibitor of Ca2+ /calmodulin-dependent kinase II) and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7, a calmodulin antagonist) significantly reduced it. Moreover, L-type, but not P- or N-type, voltage-dependent Ca(2+)-channel blockers suppressed enhancement of the uptake. These results indicate that Ca(2+)-dependent enhancement of [3H]5-HT uptake is mediated by activation of calmodulin-dependent protein kinases, suggesting a possibility of calmodulin-dependent regulation of in vivo 5-HT uptake.
研究了钙离子(Ca2+)对大鼠皮质突触体摄取[3H]5-羟色胺(5-HT)的影响。在Krebs-Ringer培养基中存在Ca2+时摄取增强,在0.3-5 mM Ca2+时的摄取量比无Ca2+时观察到的摄取量高2.4-2.7倍。在1 mM Ca2+浓度下,预孵育2分钟后达到最大增加。Ca2+依赖性增强的[3H]5-HT摄取反映了摄取过程中Vmax的增加。然而,与无Ca2+条件相比,在1 mM Ca2+存在下,[3H]帕罗西汀的Kd和Bmax值没有显著变化。另一方面,在用1 mM Ca2+预孵育后用无Ca2+溶液洗涤突触体后,摄取仍然增强。星形孢菌素(一种蛋白激酶C抑制剂)和渥曼青霉素(一种肌球蛋白轻链激酶抑制剂)不影响Ca2+依赖性摄取增强,而1-[N,O-双(5-异喹啉磺酰基)-N-甲基-L-酪氨酰]-4-苯基哌嗪(KN-62,一种Ca2+/钙调蛋白依赖性激酶II抑制剂)和N-(6-氨基己基)-5-氯-1-萘磺酰胺盐酸盐(W-7,一种钙调蛋白拮抗剂)显著降低了摄取。此外,L型电压依赖性Ca2+通道阻滞剂(而非P型或N型)抑制了摄取增强。这些结果表明,Ca2+依赖性增强的[3H]5-HT摄取是由钙调蛋白依赖性蛋白激酶的激活介导的,提示钙调蛋白依赖性调节体内5-HT摄取的可能性。